PHOTO
Riyadh: AbbVie, a research-based global biopharmaceutical company, today announced that it has been formally recognized as the leading pharmaceutical provider of pharmacy training for the year 2019 at King Saud University’s Annual Preceptor Retreat Day.
King Saud University’s ‘Preceptor of The Year Excellence Award’ was awarded to one company from private, government and pharmaceutical sectors, with AbbVie winning the competitive pharmaceutical category. Students from King Saud University voted for the company which had the highest quality of preceptors, as well as the most engaging training content and structure.
Dr. Aws Alshamsan, Dean of the College of Pharmacy at King Saud University, concludes, “It was my pleasure to award AbbVie the excellence in pharmaceutical training at our Annual Preceptor Retreat Day. Pharmacists are an integral part of our local communities and play a vital role in our care. With the continuous support and time invested by private pharmaceutical companies, such as AbbVie, it allows us to prepare students with the academic and science knowledge necessary, as well as inspire the next generation of Saudi pharmacists.”
Speaking about the achievement, Ashraf Daoud, general manager of AbbVie in Saudi Arabia, said, “Winning this award is testament to the dedication and unwavering commitment of our team at AbbVie. Inspiring future Saudi pharmacists to join the private pharmaceutical sector has been a core focus for AbbVie since we started our operations in the Kingdom five years ago. We are extremely proud of our partnership with King Saud University and our on-going work in training current and aspiring Saudi pharmacists to support the Government in their journey towards achieving Vision 2030.”
As part of AbbVie’s commitment to training Saudi pharmacists, AbbVie hosts a yearly Pharma Training programs especially tailored for Saudi pharmacy students and recent graduates. It helps them in building the practical experience in the pharmaceutical industry, as well as building a broad talent base prepared to meet the needs of Saudi Arabia’s dynamic healthcare market.
Hanan Almanea, a current pharmacy student from King Saud University, commented, “AbbVie stood out compared to other companies because of its captivating and engaging content. As an upcoming pharmacist, the training was extremely helpful in bringing to life what awaits me when I graduate and reinforcing the remarkable impact pharmacists can have on patients’ lives.”
-Ends-
About AbbVie
AbbVie is a global, research and development-based biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, LinkedIn or Instagram.
For further information, please contact:
Ahmed S. Dahduli
Communications Director
AbbVie
Mobile: +966 50 425 1500
Email: ahmed.dahduli@abbvie.com
Marwan Abu-Ghanem
Hill+Knowlton Strategies
Mobile: +966 56 678 3335
Email: Marwan.Abu-Ghanem@hkstrategies.com
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
